No reason to sell we have a 4 million MC with 8.7 in revenue we’ll go up slightly after sellers move on . We’re looking at no less than 20 million in 2023 .
It was a great Q for almost any OTC company. The problem lies in the lofty self imposed projections. Just the two companies acquired at the end of Q1 were estimated to generate 20 mil and 4 mil in 2023. That was in their press releases. They added very little in all of Q2. They could come out with huge numbers in Q3 and 4 who knows but so far they obviously aren't anywhere near that.
News 
Market Data 
Discover 
